Minnesota Lawmakers File Bills To Create Psychedelics Task Force To Plan For Legalization

Minnesota lawmakers are hoping to join the ranks of states that are advancing psychedelics reform this session, introducing legislation to establish a task force to study and advise on the potential legalization of substances like psilocybin, MDMA and ibogaine.

The House bill is being sponsored by Rep. Andy Smith (D), while the Senate companion is being carried by Sen. Kelly Morrison (D). These developments come as legislators work expediently to enact marijuana legalization in the state.

Under the new proposals, a “Psychedelic Medicine Task Force” would be established in order to “advise the legislature on the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state.”

I want to give a HUGE thank you to @West4MN for signing on, making this a #bipartisan bill!

— Rep. Andy Smith (@AndySmithMN) February 16, 2023

The 23-member task force would have to consist of officials and experts, including the governor or a designee, the health commissioner, two appointees from House and Senate leadership, the state attorney general or a designee, two tribal representatives, people with expertise in substance misuse treatment, public health policy experts, military veterans with mental health conditions and more.

Members would be required to “survey existing studies in the scientific literature on the therapeutic efficacy of psychedelic medicine in the treatment of mental health conditions, including depression, anxiety, post-traumatic stress disorder, and bipolar disorder, and any other mental health conditions and medical conditions for which a psychedelic medicine may provide an effective treatment option,” the billtext says.

“Psychedelic medicine may include but is not limited to the use of 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, mescaline, LSD, bufotenine, DMT, 5-MeO-DMT, 2C-B, ibogaine, salvinorin A, and ketamine,” it continues.

This task force would establish a #Psychedelic Medicine Task Force to advise the #mnleg on "the legal, medical, and policy issues associated with the legalization of psychedelic medicine in the state."

Full Text here: https://t.co/FlylSUe94H

(2/5)

— Rep. Andy Smith (@AndySmithMN) February 20, 2023

The task force would need to further need to assess whether any particular psychedelic is effective in the treatment of any of those conditions, compare that efficacy to conventional drug treatments and develop a plan that considers the “statutory changes necessary for the legalization of psychedelic medicine.” The body would also need to consider state and local regulation of the substances, as well as federal policy “with a focus on retaining state autonomy to act without conflicting with federal law.”

“The task force shall submit two reports to the chairs and ranking minority members of the legislative committees with jurisdiction over health and human services that detail the task force’s findings regarding the legalization of psychedelic medicine in the state, including the comprehensive plan developed under subdivision,” it says. “The first report must be submitted by February 1, 2024, and the second report must be submitted by January 1, 2025.”

If you live in #Minnesota please let your legislators know about this bill and encourage them to support it. As John Oliver stated in the piece, this has #bipartisan both federally and in the state.

Use this link to contact your legislators: https://t.co/pQoIWJ9iBN

(4/5)

— Rep. Andy Smith (@AndySmithMN) February 20, 2023

With the Democratic-Labor-Farmer party in the majority in the House and Senate, while holding the governorship, this session, there’s optimism about the prospects of advancing bold drug policy. That includes marijuana legalization legislation that’s moved through 10 House committees and seven Senate panels so far.

Minnesota is far from the only state where legislators are taking up psychedelics reform this year.

Last week, for example, a Washington State Senate committee voted to dramatically overhaul to a psilocybin services bill, removing sections that would have legalized use of the psychedelic drug by adults.

Oklahoma lawmakers approved bill in committee last week to promote research into the therapeutic potential of psilocybin while providing legal protections against prosecution for people with eligible conditions who possess the psychedelic.

A Hawaii House committee approved legislation last week to promote research into psilocybin and MDMA.

Iowa, Missouri, New Hampshire and Utah are also some of the latest states where lawmakers are working to advance the issue.

Virginia lawmakers rejected a bill last month that would have allow people with serious mental health conditions to possess and use psilocybin mushrooms with a doctor’s recommendation. Then, last week, a Virginia Senate-passed measure to create a psilocybin advisory board and reschedule the psychedelic was killed in a committee of the GOP-controlled House of Delegates.

Legislators in Connecticut and Massachusetts have also filed bills to revise laws governing entheogenic plants and fungi.

New York Assemblymember Linda Rosenthal (D) filed legislation to legalize certain psychedelics like psilocybin and ibogaine for adults 21 and older. Gov. Kathy Hochul (D) also recently signed a bill mandating that the state immediately reschedule or deschedule Schedule I drugs like MDMA and psilocybin if they’re reclassified under federal law.

Bipartisan Washington State senators also recently unveiled a revised bill to legalize psilocybin services for adults.

There are also psychedelics reform efforts underway in Arizona, California, Colorado, Illinois, Montana, New Jersey and Oregon.

An analysis published in an American Medical Association journal last month concluded that a majority of states will legalize psychedelics by 2037, based on statistical modeling of policy trends.

New Hampshire House Passes Marijuana Legalization Bill That’s Sponsored By Top Republican And Democratic Lawmakers

Photo elements courtesy of carlosemmaskype and Apollo.

Minnesota House-Passed Bill To Allow Whole-Plant Medical Marijuana Killed By Senate

In a lackluster finish Sunday night to Minnesota’s scheduled legislative session, Senate Republicans voted to kill provision the House passed a day earlier that would have allowed medical marijuana patients to purchase raw, whole-plant forms of cannabis.

The vote came as lawmakers left piles of unfinished business on the table ahead of an end-of-session deadline on Monday. Legislative leaders indicated they’ll be back for a special session June 12, but Senate Majority Leader Paul E. Gazelka (R) said  that lawmakers will likely focus on bills “just for COVID-19.”

In other words, patients and medical marijuana advocates will probably have to wait until this fall for another chance to overturn the state’s ban on marijuana flower.

“Next year!” tweeted state Sen. Karla Bigham (DFL). “We got you!”

Next year! We got you! @ScottDibble@MelisaFranzenhttps://t.co/jJ68yyDnQX

— Sen. Karla Bigham (@karlabigham) May 18, 2020

Since Minnesota’s medical marijuana program launched in 2015, the state has banned sales of raw cannabis flower, allowing access to only extracts in the form of liquids, pills and vaporized oils. While supporters of the whole-plant ban say it’s a necessary step to prevent smoking, medical marijuana advocates argue the policy has driven up costs while limiting treatment options.

An amendment to a health care omnibus bill approved by the House of Representatives on Saturday would have removed the prohibition on whole plant marijuana and specifically allowed for “raw cannabis.” But around noon on Sunday, the Senate voted to table that version of the omnibus bill after pushback from Senate Republicans. Hours later, senators passed a separate omnibus bill with the medical marijuana provision removed.

This was an active weekend at the #mnleg and it might leave you asking: What happened with medical #cannabis in #Minnesota? Catch up here in 60 seconds. pic.twitter.com/AYC5GnHvl5

— Minnesota Cannabis College (@MNCannabisEdu) May 18, 2020

As the Minnesota chapter of Republicans Against Marijuana Prohibition (RAMP) noted on Sunday, Senate Republicans seemed to reject the House omnibus bill specifically because of the marijuana amendment. A version of the legislation without the provision “passed the Senate unanimously 10 days ago,” the group observed. “The only change the House made was to amend the bill to allow raw cannabis for medical cannabis patients and move marijuana from Schedule I to Schedule II.” (A third House amendment barred age-related macular degeneration from the list of qualifying conditions for medical marijuana.)

#SF3560 passed the Senate unanimously 10 days ago. The only change the House made was to amend the bill to allow raw cannabis for medical cannabis patients and move marijuana from Schedule I to Schedule II. Today the Senate GOP (@mnsrc) tabled the bill to try to kill it. #mnleghttps://t.co/1NnfQ6epVo

— RAMP Minnesota (@ramp_mn) May 17, 2020

Just a day earlier, House Majority Leader Ryan Winkler (DFL) had expressed hope about the amended bill’s chances in the other chamber, saying on the House floor Saturday that he believed the Senate “agrees with” the proposal.

Sensible Change Minnesota, a drug-reform advocacy group, tweeted that the group had been told “the Senate GOP dug their heels in, and forced an agreement on the health policy bill, removing the #patientsfirst language adding raw cannabis.”

Strictly speaking, the change wouldn’t have allowed the combustion or smoking of medical marijuana. The amendment appeared in a paragraph dealing with vaporized marijuana products, replacing a provision prohibiting “dried leaves or plant form” with an allowance for “raw cannabis.” But because there’s no meaningful difference between flower meant to be vaporized and flower meant to be smoked, the shift would have ultimately made it easier for patients to legally obtain products that they could smoke if they chose to.

Advocates point out that some patients, such as people with terminal diseases, may not be concerned by the health hazards of smoking. Other patients report that inhaled cannabis flower—whether smoked or vaporized—is more effective for treating their symptoms than other marijuana products.

The ban on whole-plant marijuana “drives up costs, threatens the financial viability of cannabis businesses, and deprives patients of access to the form of medicine that works best for many,” the advocacy group Marijuana Policy Project wrote in a letter it asked supporters to send to Minnesota senators prior to their vote. “Several other states initially forbade whole plant cannabis but reversed course after realizing it was harmful to patients to do so.”

Sunday’s failure of the marijuana amendment doesn’t bode well for the chances of an even more ambitious ongoing effort in Minnesota, at least in the short term. Earlier this month, Winkler unveiled a comprehensive plan for legalizing cannabis for all adults 21 and older. The 222-page bill would tax and regulate commercial sales of the drug, expunge past marijuana-related convictions, encourage a craft cannabis industry, prioritize social equity in business licensing and even explicitly require local governments to allow state-licensed marijuana businesses, something most state cannabis laws haven’t done.

But despite teasing the new legislation as “the best legalization bill in the country,” Winkler has already acknowledged that it could have a hard time winning Senate approval. In February, he said it was “highly likely that it will take more than one year to get it done.”

The Senate’s staunch rejection Sunday of the whole-plant provision for medical marijuana patients could be an early sign of an even more contentious cannabis fight to come.

Louisiana House Approves Medical Marijuana For Any Debilitating Condition, Along With Delivery Services

This story has been updated with the correct first name of a lawmaker.